Breast Cancer News and Research

Latest Breast Cancer News and Research

Sutter Home Family Vineyards renews annual Sutter Home for Hope program

Sutter Home Family Vineyards today announced the renewal of its annual Sutter Home for Hope program. Since 2001, Sutter Home has been committed to supporting breast cancer research through the consumer-driven Capsules for Hope program and has donated more than $800,000 toward breast cancer awareness.

18 Sep 2010

CDC, Epocrates educate healthcare professionals about safe injection practices

The Centers for Disease Control and Prevention and Epocrates, Inc. are educating healthcare professionals about safe injection practices conveniently and effectively on their smartphone devices. Epocrates' EssentialPoints mobile detailing program provides healthcare professionals with key lessons that can be applied directly to patient care.

18 Sep 2010

Researchers awarded funds to assess effects of omega-3 fatty acids on breast cancer development

Two researchers at Marshall University have been awarded federal funds totaling more than $1 million to assess the effects of omega-3 fatty acids on breast cancer development.

18 Sep 2010

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.

18 Sep 2010

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

Genentech, Inc., a member of the Roche Group, today announced that information submitted by the company to the U.S. Food and Drug Administration (FDA) during the review of the supplemental Biologics License Applications (sBLAs) for Avastin (bevacizumab) for previously untreated (first-line) advanced HER2-negative breast cancer has been deemed a major amendment.

18 Sep 2010

DaVita launches Kidney Awareness Run|Walks for chronic kidney disease

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its launch of the 5th annual DaVita Kidney Awareness Run|Walks, a 10 city series of 5K events raising funds and awareness of CKD across the nation.

17 Sep 2010

Study suggests familial, contextual factors affect girls' pubertal timing

Girls in homes without a biological father are more likely to hit puberty at an earlier age, according to a new study led by researchers at the University of California, Berkeley's School of Public Health.

17 Sep 2010

Fat-derived stem cells can aid breast reconstruction after mastectomy

Fat-derived stem cells can be safely used to aid reconstruction of breast tissue after mastectomy as long as there is no evidence of active cancer, according to researchers at the University of Pittsburgh School of Medicine.

17 Sep 2010

Researchers discover chronic stress accelerates breast cancer progression

Chronic stress acts as a sort of fertilizer that feeds breast cancer progression, significantly accelerating the spread of disease in animal models, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.

17 Sep 2010

Key recommendations for better services for women with secondary breast cancer

The support provided for women with secondary breast cancer is inadequate and urgent steps are needed to provide better services for patients with this progressive incurable disease, which kills half a million women worldwide every year. Those are the key recommendations to emerge from a trio of papers in the September issue of the European Journal of Cancer Care.

16 Sep 2010

Aetna supports landmark study on BRCA testing

Testing is available to help identify if a woman is likely to face one of her gender's worst fears: inherited breast and ovarian cancer. But significant questions have been raised among doctors and public health agencies about whether these tests are being offered to the women who can most benefit - consistent with the evidence-based guidelines for this testing - and whether the information learned from testing is being put to best use.

16 Sep 2010

ESMO honors three eminent cancer specialists for their contribution towards medical research

The European Society for Medical Oncology (ESMO) honors three eminent cancer specialists for their contribution to the advancement of medical research. The awards will be presented to Hilary Calvert, Alberto Costa and Bengt Glimelius at the 35th ESMO Congress, to take place from 8-12 October in Milan, Italy.

16 Sep 2010

Consuming alcohol after diagnosis increases breast cancer recurrence risk: Study

In the Life After Cancer Epidemiology (LACE) study, 1,897 participants diagnosed with early-stage breast cancer between 1997 and 2000 and recruited on average 2 years post-breast cancer diagnosis were evaluated for the association between alcohol intake and breast cancer recurrence and death.

16 Sep 2010

Eggland's Best supports Susan G. Komen for the Cure's breast cancer advocacy efforts

Eggland's Best, Inc. (EB) is proud to support Susan G. Komen for the Cure®, the world's largest breast cancer advocacy organization. For the first time in the brand's history, Eggland's Best will display the Komen for the Cure's running ribbon logo along with a pink version of their iconic "EB" stamp on their egg varieties during the autumn of 2010.

15 Sep 2010

ESMO honors eminent cancer specialists

15 Sep 2010

Survey reveals inadequate provision for women with secondary breast cancer

57% of breast care nurses who took part in a UK survey for the charity Breast Cancer Care feel that there is inadequate provision for women with secondary breast cancer, a progressive incurable disease that kills half a million women worldwide every year after the cancer spreads to other organs. Many said that they felt ill equipped to care for women with secondary breast cancer and that their time was dominated by meeting the needs of women with primary breast cancer.

15 Sep 2010

Compandia is now CompanDX

Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.

15 Sep 2010

Study to assess impact of radiation exposure on multiple cancer risk

It is well known that exposure to radiation has multiple harmful effects - including causing cancer - but until now, it has been unclear to what extent such exposure increases a person's risk of developing more than one cancer. The first large-scale study of the relationship between radiation dose and risk of multiple cancers among atomic bomb survivors in Hiroshima and Nagasaki, Japan reveals a similar risk in the development of first and second subsequent cancers.

15 Sep 2010

Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.

15 Sep 2010

Researchers unveil watercress compound can block pathway for cancer development

The research, unveiled at a press conference today (14 September 2010), shows that the watercress compound is able to interfere with the function of a protein which plays a critical role in cancer development.

15 Sep 2010